-
Extensive cooperation across warehousing, domestic distribution, international transport and logistics
-
Tie-up to support Chinese pharma firm’s access to international markets, leveraging Kuehne+Nagel’s global pharma network
-
Further strengthens Kuehne+Nagel’s presence in China
Global logistics provider Kuehne+Nagel has announced a strategic partnership with Jointown, one of China’s largest non-state-owned pharmaceutical distribution companies, to accelerate its footprint in pharma and healthcare logistics in China.
The partnership will allow Kuehne+Nagel access to Jointown’s in-country storage and distribution network, enabling Kuehne+Nagel to comply with the highly regulated Chinese pharmaceutical and healthcare sector.
“We are pleased to be partnering with Jointown. Our cooperation perfectly meets the demands of our global clientele by enabling seamless supply chain coverage connecting China. This will enable us to accelerate our growth in the pharma and healthcare sector in China,” said Siewloong Wong, president of Kuehne+Nagel Asia Pacific.
With Covid-19 vaccines becoming widely approved for use in more countries, Jointown and Kuehne+Nagel will collaborate to manage vaccine distribution in a safe and timely manner, leveraging their respective strengths in vaccine storage and distribution both in China and other parts of the world.
The partnership comes shortly after Kuehne+Nagel announced that it has entered into a binding agreement to acquire Asian logistics company Apex.
Photo courtesy of Kuehne+Nagel
